How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study

Author:

Bermejo Fernando,Algaba Alicia,Chaparro María,Taxonera Carlos,Garrido Elena,García-Arata Isabel,Guerra Iván,Gisbert Javier P.,Olivares David,de-la-Poza Gema,López-Sanromán Antonio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference49 articles.

1. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease;Rahier;Journal of Crohn's Colitis,2009

2. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent;Keane;New England Journal of Medicine,2001

3. Targeted tuberculin testing and treatment of latent TB infection. ATS guidelines;American Thoracic Society,1999

4. BTS recommendations for assessing risk and for managing M TB infection and disease in patients due to start anti-TNF alpha treatment;British Thoracic Society Standards of Care Committee;Thorax,2005

5. Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update;López-San Román;Gastroenterologia y Hepatologia,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3